BioNTech SE (BNTX) Total Liabilities (2018 - 2025)

BioNTech SE has disclosed Total Liabilities across 8 years of filings, most recently posting $3.2 billion for Q4 2025.

• Total Liabilities for Q4 2025 came in at $3.2 billion, down 3.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.2 billion (down 3.44% YoY), and the FY2025 annual result was $3.1 billion, down 6.28% from the prior year.
• Total Liabilities came in at $3.2 billion for Q4 2025 at BioNTech SE, down from $3.3 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $6.5 billion in Q3 2021 to a low of $7.0 million in Q4 2021.
• The 5-year median for Total Liabilities is $3.3 billion (2022), against an average of $3.3 billion.
• Across the five-year window, Total Liabilities plunged 99.38% in 2021 and surged 47029.01% in 2022, its largest moves.
• BioNTech SE's Total Liabilities stood at $7.0 million in 2021, then soared by 47029.01% to $3.3 billion in 2022, then dropped by 9.69% to $3.0 billion in 2023, then increased by 12.21% to $3.3 billion in 2024, then retreated by 3.44% to $3.2 billion in 2025.
• The last three Total Liabilities figures came in at $3.2 billion (Q4 2025), $3.3 billion (Q3 2025), and $3.5 billion (Q2 2025), per Business Quant data.